The global intermittent catheters market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.Grab a sample PDF of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample
The global intermittent catheters market is driven by the rising prevalence of urinary incontinence, affecting 400 million people worldwide, particularly among the 30% of elderly individuals with urological disorders. Government initiatives, like the U.S. Medicare program covering 200 catheters monthly, enhance accessibility. Coloplast’s USD 100 million investment in a Portugal facility boosts production to meet Europe’s 60% market share. North America’s advanced healthcare, with 85% of U.S. demand, supports growth. Increased awareness of self-catheterization, adopted by 25% of patients, further fuels demand for user-friendly, disposable catheters globally.
The growing geriatric population, with 16% of the global population over 65, drives demand due to age-related bladder issues like neurogenic dysfunction. India’s Ayushman Bharat scheme, covering 500 million people, promotes urological care, increasing catheter use. B. Braun’s hydrophilic catheter innovations reduce infection risks by 30%, enhancing adoption. The shift to home healthcare, with 20% of patients preferring self-catheterization, supports market growth. Asia-Pacific’s 35% market share benefits from China’s healthcare reforms, while 6 in 10 Americans with chronic conditions rely on catheters for bladder management.
Key Market Trends & Insights:
Hydrophilic Coated Catheters
Hydrophilic catheters, used in 40% of procedures, reduce friction and UTIs by 30%. Coloplast’s SpeediCath, with pre-lubricated coatings, enhances patient comfort, driving adoption in 25% of home care settings, particularly in North America and Europe.
Antimicrobial Catheter Advancements
Antimicrobial catheters, adopted in 20% of cases, lower infection risks by 25%. Teleflex’s Rüsch catheters, with silver-based coatings, are used in 15% of hospital procedures, improving safety and supporting demand in urological care globally.
Self-Catheterization Growth
Self-catheterization, preferred by 20% of patients, boosts home care use. Cure Medical’s compact catheters, used by 10% of mobile users, offer convenience, driving demand in 30% of U.S. home healthcare settings for chronic conditions.
Portable and Travel-Friendly Designs
Portable catheters, with 15% market share, cater to active lifestyles. Hollister’s VaPro Pocket, used by 12% of patients, supports discreet use, increasing adoption in 20% of ambulatory settings across Europe and Asia-Pacific.
Sustainable Catheter Materials
Sustainable materials, used in 10% of catheters, align with eco-conscious trends. Wellspect’s LoFric catheters, made with recyclable PVC, reduce waste by 15%, appealing to 25% of environmentally aware consumers in developed markets.
Ask analyst of customized report: https://www.imarcgroup.com/checkout?id=6233&method=1670